Signal Transduction

S. Gupta, T. Barrett, A.J. Whitmarsh, J. Cavanagh, H.K. Sluss, B. Dérijard, R.J. Davis, "Selective interaction of JNK protein isoforms with transcription factors," EMBO Journal , 15(11):2760-70, 1996. (Cited about 90 times since publication) Comments by Roger J. Davis, Howard Hughes Medical Institute investigator and professor of molecular biology at the University of Massachusetts Medical School in Worcester. HANDY JNK: Howard Hughes Medical Institute's Roger Davis and colleagues lea

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

S. Gupta, T. Barrett, A.J. Whitmarsh, J. Cavanagh, H.K. Sluss, B. Dérijard, R.J. Davis, "Selective interaction of JNK protein isoforms with transcription factors," EMBO Journal , 15(11):2760-70, 1996. (Cited about 90 times since publication)

Comments by Roger J. Davis, Howard Hughes Medical Institute investigator and professor of molecular biology at the University of Massachusetts Medical School in Worcester.


HANDY JNK: Howard Hughes Medical Institute's Roger Davis and colleagues learned that JNK, a member of the mitogen-activated protein kinase family, has more isoforms--and more potential therapeutic possibilities--than researchers previously thought.
JNK may be anything but what its pronunciation suggests. This protein kinase--a member of the mitogen-activated protein kinase group--has been associated with general responses to environmental stress and with pro-inflammatory cytokines. However, this paper showed that JNK is more varied--and thus potentially more useful--than previously thought.

Roger J. Davis, Howard Hughes Medical Institute Investigator and professor of biochemistry and molecular biology ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies